Our current study represents an inaugural report delineating the role of MKRN2 in restraining ccRCC progression and promoting its apoptosis through PPP2CA-dependent deactivation of Wnt signaling. This evidence concerns the gene PPP2CA and nonpapillary renal cell carcinoma.